Clinical Trial Update: Renal Denervation by MDT-2211 System in Patients With Uncontrolled Hypertension [NA]

View source ↗

Summary

A completed clinical trial evaluated the MDT-2211 Renal Denervation System for treating patients with uncontrolled hypertension.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertension

Drugs mentioned

• MDT-2211 Renal Denervation System

Snippet

Sponsor: Medtronic Vascular | Conditions: Uncontrolled Hypertension | NA | Status: COMPLETED